mmt.hu
Raloxifene and cardioprotection in early postmenopausal women The Raloxifene Use for The Heart (RUTH) trial results were published in 2004 [1]. This was a randomized, double-blind, placebo-controlled study which recruited 10,101 women above the age of 55 years (mean age 67.5 years), with established coronary artery disease (CAD) or at high risk for CAD. Women were followed for a median period